KOSPI 5000 Is Not the End, 'February Stock Crash Theory?' / The Truth Behind Alteogen's Selloff... This Stock Formed a Double Bottom | CEO Lee Kwon-hee

코스피 5000은 끝이 아니다 '2월 주가 폭락설?' / 알테오젠 투매의 진실.. 쌍바닥 찍은 이주식 | 이권희 대표
Watch on YouTube ↗  |  January 22, 2026 at 06:32  |  23:44  |  815 Money Talk (815머니톡)
Speakers
Lee Kwon-hee — CEO, Economist

Summary

Lee Kwon-hee, CEO of Wizwave, says KOSPI above 5,000 can continue higher over the long term, but he expects a consolidation phase in late January or early February, when KOSDAQ may outperform. He views the Alteogen selloff as overdone and favors K-beauty/cosmetics, PharmaResearch, memory semiconductors led by Samsung Electronics and SK hynix, and Hyundai Motor over robot stocks. He is cautious on the solid-state battery theme and sees Korean biotech and Samyang Foods as catalyst- or earnings-dependent opportunities.

  • KOSPI crossed 5,000; Lee Kwon-hee sees long-term upside but expects late-January or February consolidation.
  • Alteogen's selloff is viewed as oversold; royalty disappointment overshadowed patent resolution and pipeline/commercialization.
  • KOSDAQ may outperform during a KOSPI rest, helped by policy expectations and earnings.
  • K-beauty/cosmetics and PharmaResearch are favored on Q4 earnings and technical setup.
  • Memory semiconductors remain leadership; Samsung Electronics and SK hynix may make higher highs.
  • Solid-state battery and robot-stock hype are viewed cautiously; Hyundai Motor and L&F are preferred.
  • Korean biotech and Samyang Foods are presented as catalyst- or earnings-dependent opportunities.
Ideas
Lee Kwon-hee CEO, Economist 1:24
KOSPI can rise further on governance
KOSPI crossing 5,000 is not the end. If corporate governance and PBR normalization proceed, treasury-share cancellation expands, and Samsung Electronics and SK hynix earnings surge, the index can move toward 6,000-7,000 over time. The speaker expects a steady upward bias this year, though the recent pace was fast.
Lee Kwon-hee CEO, Economist 4:32
Alteogen selloff overdone; still undervalued
The Alteogen selloff was overdone and looks oversold. The market focused only on the royalty rate dropping to about 2% from expected 3-5%, but ignored that this confirms the deal, resolves the patent issue, involves a company transferred from Halozyme, and leaves future exports, commercialization, and pipeline value unrecognized. The speaker still sees Alteogen as undervalued despite institutional selling.
Lee Kwon-hee CEO, Economist 7:41
KOSDAQ may outperform while KOSPI rests
While KOSPI rests in late January or early February, KOSDAQ may outperform with a delayed upward move, helped by expectations for KOSDAQ activation measures, easing bio concerns, a secondary-battery revival, and late-January earnings or news from semiconductor equipment/materials and auto parts. The speaker says the January effect could extend into a February effect.
Lee Kwon-hee CEO, Economist 8:43
Secondary battery rally is trading, not trend
The secondary-battery sector is attracting a trading rally as money rotates from robots, but the speaker views it as a trading opportunity rather than a confirmed long-term trend. The solid-state battery narrative for robots is premature, and LFP is less attractive because it is heavy and inefficient, so high-nickel chemistry remains more plausible.
Lee Kwon-hee CEO, Economist 11:34
L&F preferred over LFP, solid-state
Within the battery materials space, the speaker prefers high-nickel cathode exposure over the solid-state or LFP theme. He says a stock like L&F is better positioned if investors want to play the high-nickel route.
Lee Kwon-hee CEO, Economist 12:50
K-beauty earnings surprise likely; keep holding
The K-beauty, cosmetics, and beauty-device complex is entering a positive phase as Q4 earnings expectations build. Estimates and guidance have been lowered, customs data show improving exports, so there is potential for positive surprises; the speaker says holders should stay with the sector rather than doubt it. He highlights APR and Silicon2 as strong movers, but the main call is sector-wide.
Lee Kwon-hee CEO, Economist 13:21
PharmaResearch double bottom targets 600,000 won
PharmaResearch has completed a double-bottom setup, with a higher right shoulder after a shakeout. The speaker sees the stock going toward KRW 600,000 and says at least 50% upside is possible, supported by expected revenue around KRW 700bn and positive research reports.
Lee Kwon-hee CEO, Economist 16:06
Memory leadership supports Samsung and SK hynix
Semiconductors remain the market's leadership group. US memory names such as Micron and SanDisk have surged, Nvidia's new Rubin-related platform is expected to increase SSD and NAND demand, and NAND prices are rising again. The speaker therefore expects Samsung Electronics and SK hynix to attempt a higher high in the near term and says they are supporting KOSPI above 5,000.
Lee Kwon-hee CEO, Economist 20:34
Korean biotech rebound depends on catalysts
The Alteogen-related selloff damaged broader biotech sentiment even though many companies had no news. The speaker says the sector can rally again if catalysts appear, such as an Alteogen contract or an ABL Bio deal, but only investors who can wait should hold biotech for those catalysts.
Lee Kwon-hee CEO, Economist 20:58
Samyang Foods can rebound on results
For investors who prefer confirmed numbers, the speaker suggests a contrarian earnings-driven idea in Samyang Foods: if its results come in well, the stock can rebound, and he frames about 30% upside as a reasonable target.
Lee Kwon-hee CEO, Economist 22:20
Prefer Hyundai Motor over overheated robot stocks
Robot stocks are overheated and have risen too far without earnings. Rather than buying pure robot plays, the speaker prefers Hyundai Motor-related stocks, which combine more fundamental support with optionality from Hyundai's robot and Atlas exposure and valuation re-rating potential. He also notes autos have risen sharply short term and may need to rest.
Lee Kwon-hee CEO, Economist 22:20
Prefer Hyundai Motor over overheated robot stocks
Robot stocks are overheated and have risen too far without earnings. Rather than buying pure robot plays, the speaker prefers Hyundai Motor-related stocks, which combine more fundamental support with optionality from Hyundai's robot and Atlas exposure and valuation re-rating potential. He also notes autos have risen sharply short term and may need to rest.
Up Next

This 815 Money Talk (815머니톡) video, published January 22, 2026, features Lee Kwon-hee discussing KOSPI, 196170.KQ, KOSDAQ Composite Index, Korean secondary battery sector, L&F, Korean K-beauty and cosmetics sector, 214450.KQ, 005930.KS, 000660.KS, Korean biotech sector, 003230.KS, 005380.KS, Korean robotics sector. 12 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Lee Kwon-hee  · Tickers: KOSPI, 196170.KQ, KOSDAQ Composite Index, Korean secondary battery sector, L&F, Korean K-beauty and cosmetics sector, 214450.KQ, 005930.KS, 000660.KS, Korean biotech sector, 003230.KS, 005380.KS, Korean robotics sector